| Patient | Emily Dickinson |
|---|---|
| Date of birth | 1830-12-10 |
| Identifiers | MRN HR-NI023-SYN-TD; SSN (made up) 000-23-6081 |
| Document date | 1885-01-12 |
| Author | Lucinda Hartwell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Stage G3a A2 chronic kidney disease with hypertension in a 54-year-old woman without diabetes. Please confirm the probable cause, advise whether further tests are needed, and advise on kidney-protective treatment and follow-up. [S]
Urgency: Routine, within four weeks; please see her on the same morning as her kidney ultrasound, since she travels with difficulty. [S]
Questions for the consultant:
Several months of morning headaches, nausea, and tiredness. Blood pressure 166/98 mmHg at today's home visit; she has never been treated for hypertension. She has taken over-the-counter naproxen several times a week for the headaches, stopped today. An urgent care visit fourteen months ago recorded an eGFR of 58 and a urine albumin-creatinine ratio of 190 mg/g, which were not followed up. Today: creatinine 1.20 mg/dL (eGFR 54), potassium 4.4 mmol/L, urine albumin-creatinine ratio 240 mg/g, urine red cells 1 per high-power field, hemoglobin 12.3 g/dL, calcium 9.3 and phosphate 3.8 mg/dL, PTH 74 pg/mL, 25-hydroxyvitamin D 21 ng/mL, HbA1c 5.5 percent, LDL 134 mg/dL. KFRE 0.5 percent at 2 years and 1.6 percent at 5 years. ECG shows borderline voltage for left ventricular hypertrophy. Started today: losartan 50 mg, atorvastatin 20 mg, vitamin D3 1,000 units, and acetaminophen as needed. Never smoker; no alcohol. She has long wished to stay at home and asks for as few clinic trips as possible; video follow-up suits her [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
1 later historical claim is omitted because it describes events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, two tablets by mouth as needed for headache (over the counter) | Two tablets as needed, up to twice a day | Oral route | 1884-10-01 to 1885-01-12 | stopped | S |
| Losartan 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1885-01-12 to 1885-02-02 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1885-01-12 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1885-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a day | Two tablets every 6 hours as needed; maximum 6 tablets a day | Oral route | 1885-01-12 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic kidney disease stage G3a A2, attributed to hypertension; synthetic modern diagnosis linked to the Bright's disease entered on her death certificate | active | confirmed | N18.31 | S — Synthetic modern diagnosis. Bright's disease as her recorded cause of death is documented (D); what it meant in her case is a retrospective question (R), and no kidney test from her lifetime exists. |
| Hypertension with chronic kidney disease (hypertensive chronic kidney disease, stage 3a); synthetic modern diagnosis linked to the retrospective view that she had severe hypertension | active | confirmed | I12.9 | S — Synthetic modern diagnosis; severe hypertension is a retrospective interpretation (R, possible), and no blood pressure from her lifetime exists. |
| Vitamin D deficiency with a mildly raised PTH in chronic kidney disease | active | confirmed | E55.9 | S — Synthetic laboratory finding at the intake visit. |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| Late winter of 1848 | Lung congestion and cough; removed from her seminary for about a month | D (CLM-0002) |
| 1851 | Symptoms then thought to be consumptive, treated with a glycerine prescription for about two years until they subsided; no tuberculosis diagnosis is documented | D (CLM-0003) |
| 1863 to 1865 | Eye affliction with sensitivity to light and aching eyes, treated by a Boston ophthalmologist with dim light and no reading during two long stays in Cambridgeport; apparently cured. The diagnosis is not recorded (iritis most often proposed) | R (CLM-0004, CLM-0005, CLM-0006) |
| October 1883 | Nervous prostration after a death in her family, followed by continuing ill health | D (CLM-0010) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1885-01-12 | Body height | 163 | cm | S |
| 1885-01-12 | Body weight | 54 | kg | S |
| 1885-01-12 | Body mass index (BMI) [Ratio] | 20.3 | kg/m2 | S |
| 1885-01-12 | Systolic blood pressure | 166 | mm[Hg] | S |
| 1885-01-12 | Diastolic blood pressure | 98 | mm[Hg] | S |
| 1885-01-12 | Heart rate | 78 | /min | S |
| 1885-01-12 | Respiratory rate | 14 | /min | S |
| 1885-01-12 | Body temperature | 36.6 | Cel | S |
| 1885-01-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1885-01-12 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 1885-01-12 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1885-01-12 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 | mmol/L | 22-29 mmol/L | Normal | S |
| 1885-01-12 | Urea nitrogen [Mass/volume] in Serum or Plasma | 21 | mg/dL | 6-21 mg/dL | Normal | S |
| 1885-01-12 | Creatinine [Mass/volume] in Serum or Plasma | 1.2 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 1885-01-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1880)/1.73 sq M | 54 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 1885-01-12 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1885-01-12 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 1885-01-12 | Phosphate [Mass/volume] in Serum or Plasma | 3.8 | mg/dL | 2.5-4.5 mg/dL | Normal | S |
| 1885-01-12 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 74 | pg/mL | 15-65 pg/mL | High | S |
| 1885-01-12 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 21 | ng/mL | 30-100 ng/mL | Low | S |
| 1885-01-12 | Albumin [Mass/volume] in Serum or Plasma | 4.1 | g/dL | 3.5-5 g/dL | Normal | S |
| 1885-01-12 | Hemoglobin [Mass/volume] in Blood | 12.3 | g/dL | 12-15.5 g/dL | Normal | S |
| 1885-01-12 | Cholesterol [Mass/volume] in Serum or Plasma | 214 | mg/dL | <=199 mg/dL | High | S |
| 1885-01-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 | mg/dL | >=50 mg/dL | Normal | S |
| 1885-01-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 134 | mg/dL | <=99 mg/dL | High | S |
| 1885-01-12 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 1885-01-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 1885-01-12 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.4-4 mIU/L | Normal | S |
| 1885-01-12 | Albumin/Creatinine [Mass Ratio] in Urine | 240 | mg/g | <=30 mg/g | High | S |
| 1885-01-12 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 1 | /[HPF] | <=2 /[HPF] | Normal | S |
| 1885-01-12 | Kidney failure 2-year risk [Likelihood] by KFRE | 0.5 | % | S | ||
| 1885-01-12 | Kidney failure 5-year risk [Likelihood] by KFRE | 1.6 | % | S | ||
| 1885-01-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1885-01-12 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S |